Long-term HIV-1 remission achieved through allogeneic haematopoietic stem cell transplant from a CCR5 32/ 32 sibling donor
Por:
Myhre, AE, Meyer-Myklestad, MH, Gullaksen, HH, Sogaard, OS, Tolstrup, M, Salgado, M, Martinez-Picado, J, Holberg-Petersen, M, Juhl, AK, Schleimann, MH, Gunst, JD, Thomsen, A, Fisher, K, Bhamra, JS, Kran, AMB, Halvorsen, B, Dyrhol-Riise, AM, Reikvam, DH, Aukrust, P, Gedde-Dahl, T, Dahl, TB, Kaarbo, M and Troseid, M
Publicada:
13 abr 2026
Ahead of Print:
1 abr 2026
Resumen:
Only few cases of human immunodeficiency virus (HIV) remission have been reported after allogeneic haematopoietic stem cell transplantation (HSCT), mostly involving stem cell donors with the homozygous CCR5 Delta 32 (CCR5 Delta 32/Delta 32) mutation, which confers resistance to CCR5-tropic HIV-1. Here we report the case of a 63-year-old man in off-treatment HIV remission, 5 years after HSCT with a CCR5 Delta 32/Delta 32 sibling donor for myelodysplastic syndrome. In-depth clinical characterization including virological and immunological analyses of peripheral blood, gut and bone marrow samples revealed that full donor chimerism was achieved. Antiretroviral therapy was discontinued after 24 months, and 48 months after HSCT, no intact HIV DNA was detected in blood or gut biopsies. Replication-competent virus and HIV-specific T cell responses were absent, and HIV antibody responses showed a gradual decline. Full donor chimerism in the gut, which is the primary viral reservoir, underscores the likelihood of a cure.
Filiaciones:
Myhre, AE:
Oslo Univ Hosp, Dept Haematol, Oslo, Norway
Meyer-Myklestad, MH:
Oslo Univ Hosp, Dept Microbiol, Oslo, Norway
Oslo Univ Hosp, Dept Infect Dis, Oslo, Norway
Gullaksen, HH:
Oslo Univ Hosp, Dept Infect Dis, Oslo, Norway
Univ Oslo, Inst Clin Med, Oslo, Norway
Sogaard, OS:
Aarhus Univ Hosp, Dept Infect Dis, Aarhus, Denmark
Aarhus Univ, Dept Clin Med, Aarhus, Denmark
Tolstrup, M:
Aarhus Univ Hosp, Dept Infect Dis, Aarhus, Denmark
Aarhus Univ, Dept Clin Med, Aarhus, Denmark
:
IrsiCaixa, Barcelona, Spain
Germans Trias I Pujol Res Inst, Barcelona, Spain
Inst Salud Carlos III, CIBERINFEC, Madrid, Spain
:
IrsiCaixa, Barcelona, Spain
Germans Trias I Pujol Res Inst, Barcelona, Spain
Inst Salud Carlos III, CIBERINFEC, Madrid, Spain
Univ Vic Cent Univ Catalonia, Vic, Spain
Catalan Inst Res & Adv Studies, Barcelona, Spain
Holberg-Petersen, M:
Oslo Univ Hosp, Dept Microbiol, Oslo, Norway
Juhl, AK:
Aarhus Univ Hosp, Dept Infect Dis, Aarhus, Denmark
Aarhus Univ, Dept Clin Med, Aarhus, Denmark
Schleimann, MH:
Aarhus Univ Hosp, Dept Infect Dis, Aarhus, Denmark
Gunst, JD:
Aarhus Univ Hosp, Dept Infect Dis, Aarhus, Denmark
Aarhus Univ, Dept Clin Med, Aarhus, Denmark
Thomsen, A:
Aarhus Univ Hosp, Dept Infect Dis, Aarhus, Denmark
Aarhus Univ, Dept Clin Med, Aarhus, Denmark
Fisher, K:
Aarhus Univ Hosp, Dept Infect Dis, Aarhus, Denmark
Aarhus Univ, Dept Clin Med, Aarhus, Denmark
Bhamra, JS:
Oslo Univ Hosp, Dept Immunol & Transfus Med, Oslo, Norway
Kran, AMB:
Oslo Univ Hosp, Dept Microbiol, Oslo, Norway
Norwegian Inst Publ Hlth, Oslo, Norway
Halvorsen, B:
Univ Oslo, Inst Clin Med, Oslo, Norway
Oslo Univ Hosp, Res Inst Internal Med, Oslo, Norway
Reikvam, DH:
Oslo Univ Hosp, Dept Infect Dis, Oslo, Norway
Univ Oslo, Inst Clin Med, Oslo, Norway
Aukrust, P:
Oslo Univ Hosp, Oslo, Norway
Dahl, TB:
Oslo Univ Hosp, Res Inst Internal Med, Oslo, Norway
Kaarbo, M:
Oslo Univ Hosp, Dept Microbiol, Oslo, Norway
Troseid, M:
Univ Oslo, Inst Clin Med, Oslo, Norway
Oslo Univ Hosp, Res Inst Internal Med, Oslo, Norway
Oslo Univ Hosp, Dept Rheumatol Dermatol & Infect Dis, Sect Clin Immunol & Infect Dis, Oslo, Norway
Oslo Univ Hosp, Oslo, Norway
Vestfold Hosp Trust, Oslo, Norway
Aarhus Univ Hosp, Aarhus, Denmark
Karolinska Inst, Stockholm, Sweden
hybrid
|